stockrowHarmony Biosciences Holdings, Inc.
HRMY Healthcare Biotechnology
Harmony Biosciences Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $868.5 million, up 21.5% from fiscal 2024.
- Revenue
- +12.3%
- EPS
- −6.24%
- Free cash flow
- −29.4%
- Total debt
- −11.5%
Quarter to September 2026, against a year earlier
Follow HRMY
Alert me
Harmony Biosciences Holdings, Inc. (HRMY) Book value per share
Harmony Biosciences Holdings, Inc.'s book value per share at the end of fiscal 2025 was 15.1×, up 30.6% from 11.6× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 18.4×. Over the past ten years it has ranged from −3.8× (fiscal 2018) to 15.1× (fiscal 2025) — the current reading is the highest in ten years. Harmony Biosciences Holdings, Inc. ranks 39th of 611 Biotechnology companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 15.1× | 30.63% |
| FY2024 | 11.6× | 47.56% |
| FY2023 | 7.9× | 15.35% |
| FY2022 | 6.8× | 110.00% |
| FY2021 | 3.2× | (14.03%) |
| FY2020 | 3.8× | — |
| FY2019 | −1.5× | — |
| FY2018 | −3.8× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 18.4× | 6.43% |
| Jun 2026 | 17.2× | 9.55% |
| Mar 2026 | 15.7× | 4.02% |
| Dec 2025 | 15.1× | 4.31% |
| 26 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| HRMY Harmony Biosciences Holdings, Inc. | 18.4× |
| SRPT Sarepta Therapeutics, Inc. compare | 14.4× |
| MAZE Maze Therapeutics, Inc. compare | 7.7× |
| FTRE Fortrea Holdings Inc. compare | 5.6× |
| VIR Vir Biotechnology, Inc. compare | 5.3× |
| TRAX First Tracks Biotherapeutics, Inc. compare | 4.2× |
| TRVI Trevi Therapeutics, Inc. compare | 2.1× |
| REPL Replimune Group, Inc. compare | 1.9× |
| MESO Mesoblast Limited compare | 0.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))